Safety and Efficacy of Ultrasound Guided Vascular Access

NCT05118581 | Unknown

• 1 other identifier: Soh-Med-21-10-25
• Study Type: interventional
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

Vascular access involves central and peripheral vein accesses and arterial accesses. Central venous catheterization is widely used in clinical practice for diverse purposes, including hemodialysis for end stage renal failure, invasive hemodynamic monitoring, radiological studies, infusion of drugs that cannot be administered via peripheral vessels, administration of parenteral nutrition, vascular access in patients whose peripheral veins are difficult to be catheterized and for miscellaneous purposes that require access to large caliber vessels. Arterial cannulation is used for invasive arterial pressure monitoring and to ensure access for diagnostic and therapeutic interventions. In the United States and United Kingdom, guidelines have recommended the use of ultrasound guidance to reduce complications and improve success in central venous catheterization.

Conditions

Vascular Access; Ultrasound Guided Vascular Access

Outcome Measures

Primary Outcomes (1)

• Incidence of adverse effects of ultrasound guided vascular access

  Number of participants with adverse effects after ultrasound guided vascular access

  one year

Study Arms (1)

patients need vascular access

EXPERIMENTAL

Arterial or venous cathetrization guided by ultrasound

Device: ultrasound guided vascular access

Interventions

ultrasound guided vascular access DEVICE

Arterial or venous catheterization guided by ultrasound

patients need vascular access

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• · Adult patients who need vascular access (arterial or venous)

You may not qualify if:

• · Patients with local infection in the area targeted for vascular access.
• Patients with severe generalized infection and other skin diseases or lesions.
• patients with history of DVT of the target vein and or pulmonary embolism.
• Patients with untreated coagulopathy (INR \>1.5 or platelets \<50000mm3)

Sponsors & Collaborators

• Sohag University: lead

Central Study Contacts

Mostafa M Ahmed, resident

CONTACT

01004115144; mostafaelsayed@med.sohag.edu.eg

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: resident doctor at vascular surgery department sohag university hospital

Study Record Dates

• First Submitted: October 13, 2021
• First Posted: November 12, 2021
• Study Start: December 1, 2021
• Primary Completion: December 1, 2022
• Study Completion: December 30, 2022
• Last Updated: November 16, 2021

Record last verified: 2021-10